Access to the OR is being rationed across every device vertical at once. The reps who win will be the ones who learned to sell without standing in the room.
For most of the history of medical device sales, the job had a physical center of gravity: the room. The OR. The hallway outside it. The surgeon’s office, the lounge, the standing Tuesday visit. A rep’s entire value — the trust, the timing, the read on what a customer really needed — was built face-to-face, in person, over months and years of being there. If you could get in the room, you could build the relationship. And if you could build the relationship, you could move the business.
That center of gravity is dissolving, and it isn’t coming back.
The door is closing, and not in one specialty
It’s tempting to file this under “spine” or “ortho” or whatever corner of the market you happen to sell into. It’s bigger than that. The same forces are pressing on device selling across verticals at once, and none of them is a temporary swing you can wait out.
Hospitals have consolidated, and consolidation moved purchasing authority off the individual clinician and onto supply chain, value-analysis committees, and finance. The surgeon who used to be your champion increasingly doesn’t hold the pen. Credentialing and vendor-management platforms now gate physical access on purpose — fewer badges, tighter windows, more justification required just to be on-site. Leaner clinical-support models keep shrinking the reasons a rep gets waved into a procedure at all. And a generation of younger procurement professionals, comfortable running serious evaluations entirely through digital channels since the pandemic, has quietly made “we’ll handle this without you in the building” the default rather than the exception.
Put those together and you get a structural shift, not a rough quarter. The face time that used to be the whole job is being rationed, and the people who now decide are people a rep may never stand in a room with.
The relationship didn’t die. The venue changed.
Here’s the part that gets misread. When access shrinks, it’s easy to conclude the relationship is what’s being lost — that selling is going cold and transactional and there’s nothing a good rep can do about it. That’s not what’s happening.
The relationship still decides the deal. What changed is where it gets built. It used to be built in person, through presence — you earned trust by showing up, reading the room, being useful in the moment. Now that same trust has to be built across distance, across a longer and more crowded buying cycle, with a cast of stakeholders — clinical leadership, supply chain, finance, committee members — who each need something different and none of whom is going to give you standing OR time to win them over.
That’s a genuinely harder sale. It’s longer. It’s more procurement- and leadership-driven. It runs through email and text and shared links instead of hallway conversations. And it rewards a completely different skill than the one the old motion prized. The rep who thrived on presence and charm in the room now has to be the rep who can put exactly the right information in front of exactly the right stakeholder at exactly the right moment — without ever being in the building.
How people actually buy when you’re not in the room
Strip away the industry specifics and medical device buyers behave like every other serious buyer. Early on, they want to learn on their own terms — pull information, compare, form a view — without a salesperson steering them before they’re ready. Then, once they’ve convinced themselves something is probably the right choice, they want a human. Not to be sold. To validate, to confirm what they think they know is accurate, to ask the last couple of questions before they commit.
The research bears this out. Gartner found that 67% of B2B buyers would prefer to buy with no sales rep involved at all — and that 69% of those same buyers turn to a rep to validate what they’ve learned, including whatever AI told them. Buyers want the rep gone in the research phase and can’t finish the decision without one at the validation moment. That was already true when reps had easy access. In a world where you can’t get the face time, it stops being an interesting data point and becomes the whole game. If you can’t be in the room to push the deal along, your only real move is to be the one who armed the buyer to move it along themselves — and to still be the trusted name when they’re ready to validate.
The motion that’s actually dying
So what’s dying isn’t the rep and isn’t the relationship. It’s the interruptive, presence-dependent motion built on top of easy access — the “just checking in,” the “wanted to swing by,” the standing visit that existed as much to keep the rep visible as to help the buyer. That motion is losing its venue. You can’t drop by a room you can’t get into, and you can’t build a relationship on face time you’re no longer granted.
Killing that motion doesn’t mean reps go quiet. It means what they reach out with has to change completely. If the touch isn’t a visit and isn’t a “got a minute,” it has to be something genuinely worth having: the right piece of validated, on-brand information, delivered to the right stakeholder’s phone at the moment it’s useful to them.
Arming the rep for a cycle they can’t walk into
Picture the new motion. Instead of angling for OR time or a calendar hold, a rep sends a prospective customer a clean, mobile-friendly piece of educational content about the product — something a supply-chain director or committee member can open on their phone, explore at 10pm when it suits them, and put down when they’re done. No badge required. No meeting to schedule. Just the right information, in the format people actually use, at the moment it’s relevant.
And it’s never one piece. Device cycles run for months and move through a whole cast of stakeholders, each needing a different kind of proof — clinical evidence for one, economic rationale for another, a clear-eyed view of fit for the committee. The real advantage is arming a rep with a library of this material, deep enough to carry a buyer across the entire distributed cycle. Three touches, four, five, each one a piece of validated information the buyer genuinely wants, delivered right when it lands — and the buyer stays educated and engaged the whole way through without the rep ever needing to be in the building. The deal keeps moving. And when the buyer hits “this is probably right,” the very next thing they need is a person to validate it — and it’s the rep who taught them, not the one who kept trying to get in the door.
What this asks of a rep’s tools
If access is the thing that disappeared, the toolbox built around access is now working against you. The legacy stack — a CRM to log the visits, a content portal nobody sends from, a file drive to email attachments out of — was designed for a world where the relationship happened in person and the software just recorded activity around it. None of it was designed to help a rep build the relationship at a distance: to put a genuinely great, on-brand, validated piece of information into a specific stakeholder’s hands, at the right moment, in a form they’ll actually open.
That’s the gap we built Nuvue to close. At its core it’s a presentation and information management platform, but what we’re really building is a sales system — one where reps don’t depend on getting in the room to keep a deal alive. We put ourselves in the rep’s shoes. Instead of leaving a rep with nothing but “can I come by,” we build them a whole library of educational, validated content about their product that’s genuinely worth sending — deep enough to carry a buyer across a long, multi-stakeholder cycle — and make it effortless to get that content into a prospect’s hands in a mobile-friendly format they’ll actually engage with. The outreach stops being a request for access and becomes a reason to trust you. The buyer explores when they’re ready. And when it’s time to validate, the rep is the obvious person to call.
There’s a reason we obsess over getting reps productive fast, too. A rep who can’t quickly get the right information in front of the right stakeholder — with no face time to fall back on — has no motion left at all. Fluency with the system isn’t a nicety when the room is closed. It’s the whole job.
The takeaway
The story everyone’s telling is that shrinking hospital access is the slow death of the field rep. It gets the situation exactly backwards. Access was never the value — it was just the easiest route to the value, which was always trust, timing, and the right information at the right moment. That route is closing. The value isn’t going anywhere.
The reps who win won’t be the ones who fight hardest to get back in the room. They’ll be the ones who stop needing the room — who show up with the best information, respect the buyer enough to let them explore it on their own terms, and become the trusted person the buyer chooses to call when it’s time to decide. Our whole job is to make sure your reps are the ones holding that information, and that getting it into a buyer’s hands is the easiest thing they do all day.
Access is disappearing. The relationship doesn’t have to.